ORIFARM GENERICS A/S: Financial statements 2022
CVR: 25674030
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
ORIFARM GENERICS A/S (CVR 25674030) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 2,074,832,000 and a net result of DKK 54,462,000 compared with DKK 150,140,000 the year before. That is an increase of 18.1% compared with the year before. The profit margin was 2.6%. Equity in the 2022 report amounted to DKK 431,719,000. The solvency ratio was 32.1%. The company had 228 employees in the financial year.
- Revenue
- DKK 2,074,832,000
- Gross Profit
- DKK 261,488,000
- Profit/Loss
- DKK 54,462,000
- Equity
- DKK 431,719,000
- Total Assets
- DKK 1,345,179,000
- Employees
- 228
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 2.1B | 261.5M | 54.5M | 431.7M | 228 |
| 2021 | 1.8B | 329.3M | 150.1M | 527.3M | 181 |
| 2020 | 688.4M | 274.2M | 145.5M | 201.2M | 117 |
| 2019 | 545M | 197M | 103.9M | 145.7M | 99 |
| 2018 | 504.4M | 162.7M | 70.1M | 116.8M | 102 |
Official annual report
Keep an eye on ORIFARM GENERICS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ORIFARM GENERICS A/S has published its annual report for 2021. Revenue came to DKK 1,757,348,000, and the net result was DKK 150,140,000.
As of January 28, 2022, Dennis Dencher has joined the board of directors of ORIFARM GENERICS A/S.
About ORIFARM GENERICS A/S
ORIFARM GENERICS A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2000. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named COPYFARM A/S and A/S PSE 38 NR. 2228. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GENERICS HOLDING A/S. The company has 255 employees (2026). In 2025, the company reported revenue of DKK 2,463,585,000 and a net result of DKK 77,177,000 compared with DKK 59,860,000 the year before. Equity in the 2025 report amounted to DKK 496,304,000.